Fundz

Xeltis secures nearly €50m to advance aXess, its vascular access conduit, from the EIB and existing shareholders.

PRIVATEDec 02, 2025

Amount Raised

€50 Million

Round Type

Funding Round

EindhovenManufacturingBiotechnologyHealth Care

Investors

Invest NlEQTEuropean Investment Bank

Description

Xeltis has secured nearly €50m in financing, including €37.5m from the EIB and €10m from existing investors like EQT. This funding will support the commercialization of aXess, enhancing production and workforce. The investment follows promising clinical trial results for the product. Xeltis is set to advance towards bringing this innovative treatment to market.

Quick answer

Xeltis raised €50 Million in a Funding Round round, dated December 2, 2025. Investors: Invest Nl, EQT and European Investment Bank. Xeltis is based in Eindhoven, North Brabant, Netherlands.

How much did Xeltis raise?
Xeltis raised €50 Million in a Funding Round round on December 2, 2025.
Who invested in Xeltis?
Invest Nl, EQT and European Investment Bank are named as investors in this round.
What does Xeltis do?
Xeltis is a medtech company developing transformative implants that enable the natural creation of living and long-lasting vessels.
Where is Xeltis based and how big is it?
Xeltis is based in Eindhoven, North Brabant, Netherlands. Fundz records about 85 employees.
Who are the decision-makers at Xeltis?
Fundz holds 2 contacts at Xeltis, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Xeltis that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $134M on January 16, 2026.
  • Conavi Medical raised $700K (Seed) on January 13, 2026.
  • Route 92 Medical raised $50M on January 13, 2026.
  • Surgerii Robotics raised $100M (Series D) on January 7, 2026.
  • Harvard Apparatus Regenerative Technology raised $700K on December 30, 2025.
  • CASI Pharmaceuticals raised $5M on December 27, 2025.

Who to call at Xeltis, and when

A new round usually means Xeltis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xeltis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xeltis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xeltis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xeltis

Location

Eindhoven, North Brabant, Netherlands

About

Xeltis is a medtech company developing transformative implants that enable the natural creation of living and long-lasting vessels. The Company seeks to address the limitations of currently available options for the millions of people requiring hemodialysis access grafts or cardiovascular replacements every year. Xeltis' proprietary endogenous tissue restoration (ETR) platform utilizes an advanced polymer implant which regenerates the patient's own tissue before gradually being absorbed and leaving new, living, and long-lasting vessels in place.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xeltis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsEliane S., Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Xeltis's next move

See what Strategic adds

Xeltis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.